Health Canada grants marketing approval for Takeda ’s multiple myeloma treatment

Health Canada has approved Japanese-based Takeda Pharmaceutical Company ’s Ninlaro (ixazomib) capsules, in combination with lenalidomide and dexamethasone, to treat patients with multiple myeloma (MM).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news